MASI
Price
$162.55
Change
+$4.62 (+2.93%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
7.66B
19 days until earnings call
NVRO
Price
$5.84
Change
-$0.00 (-0.00%)
Updated
Apr 2 closing price
Capitalization
525.59M
6 days until earnings call
Ad is loading...

MASI vs NVRO

Header iconMASI vs NVRO Comparison
Open Charts MASI vs NVROBanner chart's image
Masimo
Price$162.55
Change+$4.62 (+2.93%)
Volume$21.53K
Capitalization7.66B
NEVRO
Price$5.84
Change-$0.00 (-0.00%)
Volume$753.6K
Capitalization525.59M
MASI vs NVRO Comparison Chart
Loading...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MASI vs. NVRO commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MASI is a StrongBuy and NVRO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (MASI: $157.76 vs. NVRO: $5.84)
Brand notoriety: MASI and NVRO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MASI: 72% vs. NVRO: 70%
Market capitalization -- MASI: $7.66B vs. NVRO: $525.59M
MASI [@Medical Specialties] is valued at $7.66B. NVRO’s [@Medical Specialties] market capitalization is $525.59M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MASI’s FA Score shows that 1 FA rating(s) are green whileNVRO’s FA Score has 0 green FA rating(s).

  • MASI’s FA Score: 1 green, 4 red.
  • NVRO’s FA Score: 0 green, 5 red.
According to our system of comparison, MASI is a better buy in the long-term than NVRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MASI’s TA Score shows that 6 TA indicator(s) are bullish while NVRO’s TA Score has 2 bullish TA indicator(s).

  • MASI’s TA Score: 6 bullish, 2 bearish.
  • NVRO’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, MASI is a better buy in the short-term than NVRO.

Price Growth

MASI (@Medical Specialties) experienced а +4.01% price change this week, while NVRO (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.08%. For the same industry, the average monthly price growth was -6.75%, and the average quarterly price growth was -2.65%.

Reported Earning Dates

MASI is expected to report earnings on Aug 12, 2025.

NVRO is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+4.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MASI($7.66B) has a higher market cap than NVRO($526M). NVRO has higher P/E ratio than MASI: NVRO (147.06) vs MASI (95.93). NVRO YTD gains are higher at: 56.989 vs. MASI (-4.561). MASI has higher annual earnings (EBITDA): 237M vs. NVRO (-78.31M). NVRO has more cash in the bank: 323M vs. MASI (163M). NVRO has less debt than MASI: NVRO (216M) vs MASI (970M). MASI has higher revenues than NVRO: MASI (2.05B) vs NVRO (425M).
MASINVROMASI / NVRO
Capitalization7.66B526M1,457%
EBITDA237M-78.31M-303%
Gain YTD-4.56156.989-8%
P/E Ratio95.93147.0665%
Revenue2.05B425M482%
Total Cash163M323M50%
Total Debt970M216M449%
FUNDAMENTALS RATINGS
MASI vs NVRO: Fundamental Ratings
MASI
NVRO
OUTLOOK RATING
1..100
7240
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9394
PRICE GROWTH RATING
1..100
5649
P/E GROWTH RATING
1..100
1397
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVRO's Valuation (87) in the Medical Specialties industry is in the same range as MASI (90). This means that NVRO’s stock grew similarly to MASI’s over the last 12 months.

NVRO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MASI (100). This means that NVRO’s stock grew similarly to MASI’s over the last 12 months.

MASI's SMR Rating (93) in the Medical Specialties industry is in the same range as NVRO (94). This means that MASI’s stock grew similarly to NVRO’s over the last 12 months.

NVRO's Price Growth Rating (49) in the Medical Specialties industry is in the same range as MASI (56). This means that NVRO’s stock grew similarly to MASI’s over the last 12 months.

MASI's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for NVRO (97). This means that MASI’s stock grew significantly faster than NVRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MASINVRO
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 23 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 23 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 23 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 23 days ago
66%
Advances
ODDS (%)
Bullish Trend 23 days ago
72%
Bullish Trend 30 days ago
70%
Declines
ODDS (%)
Bearish Trend 9 days ago
65%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 23 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 23 days ago
58%
View a ticker or compare two or three
Ad is loading...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BUFG23.130.25
+1.09%
FT Vest Buffered Allocation Gr ETF
PRF38.300.40
+1.06%
Invesco RAFI US 1000 ETF
FLEE31.360.22
+0.72%
Franklin FTSE Europe ETF
BHV10.260.05
+0.49%
BlackRock Virginia Muni
XBIL50.140.01
+0.02%
US Treasury 6 Month Bill ETF

MASI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with INSP. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then INSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
+5.71%
INSP - MASI
50%
Loosely correlated
-0.23%
HBIO - MASI
45%
Loosely correlated
+0.97%
VCYT - MASI
41%
Loosely correlated
+1.08%
PODD - MASI
40%
Loosely correlated
+0.95%
MMSI - MASI
39%
Loosely correlated
+2.47%
More

NVRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVRO has been loosely correlated with INSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NVRO jumps, then INSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVRO
1D Price
Change %
NVRO100%
N/A
INSP - NVRO
47%
Loosely correlated
-0.23%
SIBN - NVRO
40%
Loosely correlated
+1.39%
NVST - NVRO
36%
Loosely correlated
+3.63%
GH - NVRO
35%
Loosely correlated
+4.20%
MASI - NVRO
33%
Loosely correlated
+5.71%
More